קבומטיקס 20 מג Izrael - hebrajski - Ministry of Health

קבומטיקס 20 מג

medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 20 mg - cabozantinib

קבומטיקס 40 מג Izrael - hebrajski - Ministry of Health

קבומטיקס 40 מג

medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 40 mg - cabozantinib

קבומטיקס 60 מג Izrael - hebrajski - Ministry of Health

קבומטיקס 60 מג

medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 60 mg - cabozantinib

סוטנט 12.5 מג Izrael - hebrajski - Ministry of Health

סוטנט 12.5 מג

pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 12.5 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

סוטנט 25 מג Izrael - hebrajski - Ministry of Health

סוטנט 25 מג

pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 25 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

סוטנט 50 מג Izrael - hebrajski - Ministry of Health

סוטנט 50 מג

pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 50 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

אסטו 10 Izrael - hebrajski - Ministry of Health

אסטו 10

unipharm ltd, israel - escitalopram as oxalate - טבליה - escitalopram as oxalate 10 mg - escitalopram

אסטו 20 Izrael - hebrajski - Ministry of Health

אסטו 20

unipharm ltd, israel - escitalopram as oxalate - טבליה - escitalopram as oxalate 20 mg - escitalopram

אסטו 15 Izrael - hebrajski - Ministry of Health

אסטו 15

unipharm ltd, israel - escitalopram as oxalate - טבליות מצופות פילם - escitalopram as oxalate 15 mg - escitalopram

טופיסלן Izrael - hebrajski - Ministry of Health

טופיסלן

trima israel pharmaceutical products maabarot ltd - flumetasone pivalate; salicylic acid - משחה - salicylic acid 3 %w/w; flumetasone pivalate 0.02 %w/w - flumetasone - flumetasone - for the treatment of corticosteroid responsive dermatoses especially in hyperkeratotic conditions.